Yüklüyor......
Safe discontinuation of nilotinib in a patient with chronic myeloid leukemia: a case report
INTRODUCTION: Although there is a considerable amount of data in the literature on safe discontinuation of first-generation tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia, little is known about discontinuation of second-generation tyrosine kinase inhibitor therapy. Most...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4160914/ https://ncbi.nlm.nih.gov/pubmed/25194418 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1752-1947-8-295 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|